Biogen Shares Soar to All-Time High On Alzheimer's Drug Approval - Yahoo Movies UK

Retrieved on: 2024-03-31 18:49:43

Tags for this article:

Spinal muscular atrophy

Biogen

Aducanumab

u.s. food and drug administration

Click the tags to see associated articles and topics

Biogen Shares Soar to All-Time High On Alzheimer's Drug Approval - Yahoo Movies UK. View article details on hiswai:

Summary

Biogen's stock jumped after the FDA approved its Alzheimer’s drug ADUHELM, marking a significant advance in biotech and providing hope for diseases like spinal muscular atrophy. This is Biogen's first Alzheimer's therapy approval in nearly 20 years.

Article found on: uk.movies.yahoo.com

View Original Article